News Focus
News Focus
icon url

Talon38

02/17/22 2:00 AM

#351539 RE: boi568 #351454

Boi....we need Anavex to put Acadia/ Nuplaxid on the back burner with 2-73 efficacy for PDD and Alzheimer's. Acadia is using Biogen's playbook in finding any track to get however small a market share.

-------

https://www.fiercepharma.com/pharma/after-shocking-fda-about-face-acadia-revives-nuplazid-narrower-alzheimer-s-focus?utm_source=email&utm_medium=email&utm_campaign=LS-NL-FierceBiotech+Tracker&oly_enc_id=6344A1822112C6Z